ProShare Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30M | Buy |
|
|||||
|
2025
Q1 | $30.7M | Buy |
|
|||||
|
2024
Q4 | $30.3M | Buy |
|
|||||
|
2024
Q3 | $32.8M | Buy |
|
|||||
|
2024
Q2 | $36.5M | Sell |
|
|||||
|
2024
Q1 | $37.5M | Buy |
|
|||||
|
2023
Q4 | $37.3M | Sell |
|
|||||
|
2023
Q3 | $43.3M | Buy |
|
|||||
|
2023
Q2 | $42.6M | Sell |
|
|||||
|
2023
Q1 | $43.9M | Buy |
|
|||||
|
2022
Q4 | $39.2M | Sell |
|
|||||
|
2022
Q3 | $41.7M | Sell |
|
|||||
|
2022
Q2 | $38.3M | Sell |
|
|||||
|
2022
Q1 | $59.1M | Sell |
|
|||||
|
2021
Q4 | $70.9M | Buy |
|
|||||
|
2021
Q3 | $60.6M | Buy |
|
|||||
|
2021
Q2 | $66.9M | Sell |
|
|||||
|
2021
Q1 | $56.3M | Buy |
|
|||||
|
2020
Q4 | $43.6M | Buy |
|
|||||
|
2020
Q3 | $44.6M | Buy |
|
|||||
|
2020
Q2 | $37.1M | Sell |
|
|||||
|
2020
Q1 | $44M | Sell |
|
|||||
|
2019
Q4 | $59.4M | Buy |
|
|||||
|
2019
Q3 | $41.8M | Sell |
|
|||||
|
2019
Q2 | $42.6M | Sell |
|
|||||
|
2019
Q1 | $51.6M | Sell |
|
|||||
|
2018
Q4 | $65.8M | Buy |
|
|||||
|
2018
Q3 | $70.2M | Sell |
|
|||||
|
2018
Q2 | $67M | Sell |
|
|||||
|
2018
Q1 | $69.5M | Buy |
|
|||||
|
2017
Q4 | $70.6M | Buy |
|
|||||
|
2017
Q3 | $59M | Buy |
|
|||||
|
2017
Q2 | $50.3M | Buy |
|
|||||
|
2017
Q1 | $45M | Sell |
|
|||||
|
2016
Q4 | $49.7M | Buy |
|
|||||
|
2016
Q3 | $47.7M | Sell |
|
|||||
|
2016
Q2 | $49.4M | Buy |
|
|||||
|
2016
Q1 | $52.9M | Sell |
|
|||||
|
2015
Q4 | $84.4M | Buy |
|
|||||
|
2015
Q3 | $74.8M | Buy |
|
|||||
|
2015
Q2 | $88.1M | Sell |
|
|||||
|
2015
Q1 | $100M | Sell |
|
|||||
|
2014
Q4 | $81.1M | Buy |
|
|||||
|
2014
Q3 | $53M | Buy |
|
|||||
|
2014
Q2 | $50.1M | Sell |
|
|||||
|
2014
Q1 | $57.8M | Buy |
|
|||||
|
2013
Q4 | $39.4M | Buy |
|
|||||
|
2013
Q3 | $22.8M | Sell |
|
|||||
|
2013
Q2 | $20.7M | Buy |
|